Sign in

CIK 0001478320

  • Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
270907024
Phone
+1 206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$14,724,890
in 17 filings, $14.5M under 10b5-1 plans

Net −$14,724,890. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-18 PISKEL KYLE Chief Financial Officer Sale −3,115 $13.04 $41K 256,725
2026-03-11 PISKEL KYLE Chief Financial Officer Sale −18,672 $13.17 $246K 259,840
2026-03-04 PISKEL KYLE Chief Financial Officer Grant or award +61,875 278,512
2026-02-04 PISKEL KYLE Chief Financial Officer Exercise or conversion 10b5-1 +2,145 $12.14 $26K 218,782
2026-02-04 PISKEL KYLE Chief Financial Officer Sale 10b5-1 −2,145 $18.46 $40K 216,637
2026-02-04 PISKEL KYLE Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −2,145 2,146
2026-01-12 PISKEL KYLE Chief Financial Officer Exercise or conversion 10b5-1 +4,290 $12.14 $52K 220,927
2026-01-12 PISKEL KYLE Chief Financial Officer Sale 10b5-1 −4,290 $18.00 $77K 216,637
2026-01-12 PISKEL KYLE Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −4,290 4,291
2025-11-28 PISKEL KYLE Chief Financial Officer Exercise or conversion 10b5-1 +11,980 $6.55 $78K 281,323
2025-11-28 PISKEL KYLE Chief Financial Officer Exercise or conversion 10b5-1 +3,750 $7.80 $29K 285,073
2025-11-28 PISKEL KYLE Chief Financial Officer Exercise or conversion 10b5-1 +94,384 $12.14 $1.1M 379,457
2025-11-28 PISKEL KYLE Chief Financial Officer Sale 10b5-1 −162,820 $19.50 $3.2M 216,637
2025-11-28 PISKEL KYLE Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −11,980 0
2025-11-28 PISKEL KYLE Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −3,750 0
2025-11-28 PISKEL KYLE Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −94,384 8,581
2025-11-17 PISKEL KYLE Chief Financial Officer Sale −238 $14.05 $3K 269,343
2025-05-16 PISKEL KYLE Chief Financial Officer Sale −1,929 $8.89 $17K 269,581
2025-05-16 PISKEL KYLE Chief Financial Officer Sale −1,929 $8.89 $17K 277,396
2025-05-15 PISKEL KYLE Chief Financial Officer Grant or award +7,815 279,325

Page 1 of 3 · 41 trades